Summary

The global IVD quality control market is projected to reach USD 1.4 billion by 2026 from USD 1.1 billion in 2021, at a CAGR of 5.3% during the forecast period. IVD testing plays a significant role in clinical decision-making. The growth of the IVD quality control market is primarily driven by the rising number of accredited clinical laboratories, rising geriatric population, rising demand for external quality assessment programs, increasing adoption of and POC instruments in developed regions and increasing adoption of third-party quality controls. The rising focus on multi-analyte controls is also expected to offer significant growth opportunities for the market in the coming years. The use of quality control products is, however, not mandatory for all clinical laboratories in many countries. The lack of regulations for these products is expected to adversely affect the market growth
The product & service segment holds the highest share of the total IVD quality control market during the forecast period.
Based on product & service, the IVD quality control market is segmented into quality control products, data management solutions, and quality assurance services. The quality control products segment accounted for the largest share of the IVD quality control market in 2020. The increasing number of accredited laboratories and mandates for the use of quality controls from regulatory bodies to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.

Serum based controls drive the growth of the quality control products segment during the forecast period.
Based on type, the IVD quality control products market is segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls, and others. Serum/plasma-based controls are highly preferred by laboratories; this segment accounted for the largest share of the quality control products market in 2020. The greater uptake of serum/plasma-based quality controls among laboratories and the wide application areas of these controls for various IVD tests are driving the market growth

Molecular diagnostics segment accounted for the highest CAGR of the global IVD quality control market
Based on technology, the IVD quality control market is broadly segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other technologies. The molecular diagnostics segment has the highest CAGR for the forecast period. With the increased non-communicable disease burden, molecular diagnostic tests have been used in the field of oncology widely. Technological advancement in the field of molecular diagnostics is another driver for the growth of this industry.

Third-party controls accounted for the highest share for the IVD quality control market
Based on manufacturer, the IVD quality control market is segmented into third-party controls and OEM controls. The third-party controls segment accounted for the largest share of the global IVD quality control market in 2020. The large share of this segment can be attributed to the increasing use of third-party quality controls across the globe to verify the accuracy and reliability of tests

Based on end users, hospitals accounted for the highest share of the global IVD quality control market during the forecast period.
The key end users of IVD quality controls studied in this report include hospitals, clinical laboratories, research & academic institutes, and other end users. The hospitals segment accounted for the largest share of the IVD quality control market in 2020, owing to the large volume of diagnostic tests carried out in hospitals.

North America is expected to account for the highest share for players operating in the global IVD quality control market
Geographically, the global IVD quality control market studied in this report is divided into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global IVD quality control market, followed by Europe. The APAC region has the highest CAGR of the global IVD quality control market. The Asia Pacific is considered the most lucrative market for IVD quality controls, owing to the region’s large patient population and rising healthcare needs. Market players are focusing on improving laboratory test quality in emerging APAC countries by working with local government bodies, agencies, and academic societies to offer external QC for standardizing laboratory testing procedures and ensure accuracy.


Break of primary participants was as mentioned below:
• By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
• By Designation – C-level–30%, Director-level–50%, Others–20%
• By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%

Key players in the IVD quality control Market
Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.

Research Coverage:
The report analyzes the IVD quality control market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, manufacturer type, end user, and region. The report also includes a product portfolio matrix of various IVD quality control available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global IVD quality control market. The report analyzes this market by product, technology, manufacturer type, end user, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global IVD quality control market
• Market Development: Comprehensive information on the lucrative emerging markets by product, technology, manufacturer type, end user, and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global IVD quality control market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global IVD quality control market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 36
1.1 OBJECTIVES OF THE STUDY 36
1.2 MARKET DEFINITION 36
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 37
1.3 MARKET SCOPE 37
1.3.1 MARKETS COVERED 37
1.3.2 YEARS CONSIDERED FOR THE STUDY 38
1.3.3 CURRENCY 38
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 38
1.4 STAKEHOLDERS 39
1.5 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
FIGURE 1 RESEARCH DESIGN 41
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
FIGURE 2 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 44
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND- SIDE PARTICIPANTS 45
2.2 MARKET SIZE ESTIMATION 46
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 46
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BIO-RAD LABORATORIES, INC. 47
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: IVD QUALITY CONTROL MARKET (2020) 47
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE IVD QUALITY CONTROL MARKET (2021–2026) 49
FIGURE 9 CAGR PROJECTIONS 49
FIGURE 10 TOP-DOWN APPROACH 50
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 51
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 51
2.4 MARKET SHARE ANALYSIS 51
2.5 ASSUMPTIONS FOR THE STUDY 52
2.6 RISK ASSESSMENT 53
TABLE 2 RISK ASSESSMENT: IVD QUALITY CONTROL MARKET 53
2.7 LIMITATIONS 53
2.7.1 METHODOLOGY-RELATED LIMITATIONS 53
2.7.2 SCOPE-RELATED LIMITATIONS 53
3 EXECUTIVE SUMMARY 54
FIGURE 12 IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 54
FIGURE 13 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 55
FIGURE 14 IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2021 VS. 2026 (USD MILLION) 55
FIGURE 15 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 56
FIGURE 16 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 56
FIGURE 17 IVD QUALITY CONTROL MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 57
FIGURE 18 IVD QUALITY CONTROL MARKET: GEOGRAPHIC SNAPSHOT 58
4 PREMIUM INSIGHTS 59
4.1 IVD QUALITY CONTROL MARKET OVERVIEW 59
FIGURE 19 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET GROWTH 59
4.2 APAC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY AND COUNTRY (2020) 60
FIGURE 20 IMMUNOCHEMISTRY TO COMMAND THE LARGEST SHARE OF THE APAC IVD QUALITY CONTROL MARKET IN 2020 60
4.3 IVD QUALITY CONTROL MARKET: GEOGRAPHIC MIX 61
FIGURE 21 CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 61
4.4 IVD QUALITY CONTROL MARKET: DEVELOPED VS DEVELOPING MARKETS 61
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHEST CAGR DURING THE FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 MARKET DYNAMICS 62
FIGURE 23 IVD QUALITY CONTROL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
5.1.1 MARKET DRIVERS 63
5.1.1.1 Increasing number of accredited clinical laboratories 63
FIGURE 24 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION,
BY ORGANIZATION (2018) 63
5.1.1.2 Growing adoption of third-party quality controls 64
5.1.1.3 Rising demand for external quality assessment support 64
5.1.1.4 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases 65
TABLE 3 ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION
(2019–2050) 65
FIGURE 25 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 66
FIGURE 26 GLOBAL CANCER INCIDENCE, 2015–2040 66
5.1.1.5 Increasing adoption of POC instruments in developed regions 67
TABLE 4 MARKET DRIVERS: IMPACT ANALYSIS 67
5.1.2 MARKET RESTRAINTS 67
5.1.2.1 Additional costs and budget constraints in hospitals and laboratories 67
5.1.2.2 Unfavorable reimbursement scenario for IVD tests 68
TABLE 5 MARKET RESTRAINTS: IMPACT ANALYSIS 68
5.1.3 MARKET OPPORTUNITIES 68
5.1.3.1 Rising demand for multi-analyte controls 68
TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS 69
5.1.4 MARKET CHALLENGES 69
5.1.4.1 Stringent product approval process 69
5.1.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries 69
TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS 69
5.2 INDUSTRY TRENDS 70
5.2.1 LYOPHILIZED/FREEZE-DRIED CONTROLS 70
TABLE 8 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED
BY KEY MARKET PLAYERS 70
5.2.2 TRENDS ON ANALYTE SOURCE: HUMAN VS. ANIMAL ORIGIN 70
5.2.3 CONSOLIDATION OF LABORATORIES 71
5.3 VALUE CHAIN ANALYSIS 71
FIGURE 27 IVD QUALITY CONTROL MARKET: VALUE CHAIN ANALYSIS 71
5.4 SUPPLY CHAIN ANALYSIS 72
FIGURE 28 IVD QUALITY CONTROL MARKET: SUPPLY CHAIN ANALYSIS 73
5.5 ECOSYSTEM MARKET MAP 73
FIGURE 29 IVD QUALITY CONTROL MARKET: ECOSYSTEM MARKET MAP 74
5.6 PORTER’S FIVE FORCES ANALYSIS 74
5.6.1 THREAT FROM NEW ENTRANTS 74
5.6.2 THREAT FROM SUBSTITUTES 75
5.6.3 BARGAINING POWER OF SUPPLIERS 75
5.6.4 BARGAINING POWER OF BUYERS 75
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 76
5.7 REGULATORY ANALYSIS 76
5.7.1 NORTH AMERICA 76
5.7.1.1 US 76
TABLE 9 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL 77
TABLE 10 US: TIME, COST, AND COMPLEXITY OF REGISTRATION 77
5.7.1.2 Canada 78
TABLE 11 CANADA: CLASSIFICATION OF IVD PRODUCTS 78
TABLE 12 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 78
5.7.2 EUROPE 78
TABLE 13 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES 79
TABLE 14 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION 79
5.7.3 ASIA PACIFIC 80
5.7.3.1 Japan 80
TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 80
5.7.3.2 China 81
TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 81
5.7.3.3 India 81
TABLE 17 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION 82
5.8 IMPACT OF COVID-19 ON THE IVD QUALITY CONTROL MARKET 82
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 83
FIGURE 31 ROCHE DIAGNOSTICS.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 83
FIGURE 32 BIO-RAD LABORATORIES, INC.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 84
FIGURE 33 ABBOTT LABORATORIES: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 84
5.9 PATENT ANALYSIS 85
5.9.1 PATENT PUBLICATION TRENDS FOR IVD QUALITY CONTROLS 85
FIGURE 34 PATENT PUBLICATION TRENDS (2011–AUGUST 2021) 85
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 86
FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR IVD QUALITY CONTROL PATENTS (JANUARY 2011–AUGUST 2021) 86
FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR IVD QUALITY CONTROL PATENTS (JANUARY 2011–AUGUST 2021) 87
5.10 TECHNOLOGY ANALYSIS 87
5.10.1 KEY TECHNOLOGIES 88
5.10.1.1 Analyte extraction 88
5.10.1.1.1 Specimen pooling 88
5.10.1.1.2 Human monoclonals 88
5.10.1.2 Specimen processing 88
5.10.1.2.1 Inactivation 88
5.10.1.2.2 Dilution 89
5.10.1.3 Preservation 89
5.10.2 ADJACENT TECHNOLOGIES 89
5.10.2.1 Sensor-based quality control 89
5.10.3 COMPLEMENTARY TECHNOLOGIES 89
5.10.3.1 Storage 89
5.10.3.2 Transport 90
5.10.3.3 Temperature control 90
5.10.3.4 Temperature monitoring 90

6 IVD QUALITY CONTROL MARKET, BY PRODUCT AND SERVICE 91
6.1 INTRODUCTION 92
TABLE 18 IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 92
6.2 QUALITY CONTROL PRODUCTS 92
TABLE 19 QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 20 QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 93
6.2.1 SERUM/PLASMA-BASED CONTROLS 94
6.2.1.1 Greater stability and accuracy of diagnostic test results to increase the demand for serum/plasma-based controls 94
TABLE 21 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 94
TABLE 22 SERUM/PLASMA-BASED QUALITY CONTROL PRODUCTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 95
6.2.2 WHOLE BLOOD-BASED CONTROLS 95
6.2.2.1 Rising need to ensure high-quality clinical test results to drive the whole blood-based controls market 95
TABLE 23 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 96
TABLE 24 WHOLE BLOOD-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 97
6.2.3 URINE-BASED CONTROLS 97
6.2.3.1 The growing incidence of kidney diseases increase the need for urine-based controls 97
TABLE 25 URINE-BASED IVD CONTROLS OFFERED BY KEY MARKET PLAYERS 98
TABLE 26 URINE-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
6.2.4 OTHER CONTROLS 99
TABLE 27 OTHER CONTROLS OFFERED BY KEY MARKET PLAYERS 100
TABLE 28 OTHER QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
6.3 DATA MANAGEMENT SOLUTIONS 101
6.3.1 RISING FOCUS ON IMPROVING THE ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH 101
TABLE 29 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 102
TABLE 30 DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
6.4 QUALITY ASSURANCE SERVICES 103
6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE THE DEMAND FOR QUALITY ASSURANCE SERVICES 103
TABLE 31 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS 104
TABLE 32 QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 105
7 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY 106
7.1 INTRODUCTION 107
TABLE 33 IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 107
7.2 IMMUNOCHEMISTRY 107
7.2.1 FOCUS ON MONITORING THE PRECISION OF IMMUNOASSAY TESTS TO DRIVE THE ADOPTION OF IMMUNOASSAY CONTROLS 107
TABLE 34 QUALITY CONTROLS FOR IMMUNOCHEMISTRY OFFERED BY KEY MARKET PLAYERS 108
TABLE 35 IVD QUALITY CONTROL MARKET FOR IMMUNOCHEMISTRY, BY COUNTRY, 2019–2026 (USD MILLION) 109
7.3 CLINICAL CHEMISTRY 109
7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES TO PROVIDE OPPORTUNITIES FOR MARKET GROWTH 109
TABLE 36 QUALITY CONTROLS FOR CLINICAL CHEMISTRY OFFERED BY KEY MARKET PLAYERS 110
TABLE 37 IVD QUALITY CONTROL MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2019–2026 (USD MILLION) 111
7.4 MOLECULAR DIAGNOSTICS 111
7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS 111
TABLE 38 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED
BY KEY MARKET PLAYERS 112
TABLE 39 IVD QUALITY CONTROL MARKET FOR MOLECULAR DIAGNOSTICS,
BY COUNTRY, 2019–2026 (USD MILLION) 113
7.5 MICROBIOLOGY 114
7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH 114
TABLE 40 QUALITY CONTROLS FOR MICROBIOLOGY OFFERED BY KEY MARKET PLAYERS 114
TABLE 41 IVD QUALITY CONTROL MARKET FOR MICROBIOLOGY, BY COUNTRY,
2019–2026 (USD MILLION) 115
7.6 HEMATOLOGY 115
7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS 115
TABLE 42 QUALITY CONTROLS FOR HEMATOLOGY OFFERED BY KEY MARKET PLAYERS 116
TABLE 43 IVD QUALITY CONTROL MARKET FOR HEMATOLOGY, BY COUNTRY,
2019–2026 (USD MILLION) 117
7.7 COAGULATION & HEMOSTASIS 117
7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE
THE NEED FOR COAGULATION & HEMOSTASIS TESTING 117
TABLE 44 QUALITY CONTROLS FOR COAGULATION & HEMOSTASIS OFFERED
BY KEY MARKET PLAYERS 118
TABLE 45 IVD QUALITY CONTROL MARKET FOR COAGULATION & HEMOSTASIS,
BY COUNTRY, 2019–2026 (USD MILLION) 119
7.8 OTHER TECHNOLOGIES 120
TABLE 46 QUALITY CONTROLS FOR OTHER TECHNOLOGIES OFFERED BY KEY MARKET PLAYERS 120
TABLE 47 IVD QUALITY CONTROL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION) 121
8 IVD QUALITY CONTROL MARKET, BY MANUFACTURER 122
8.1 INTRODUCTION 123
TABLE 48 IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 123
8.2 THIRD-PARTY CONTROLS 123
TABLE 49 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 50 THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 124
8.2.1 INDEPENDENT CONTROLS 125
8.2.1.1 Increased preference for independent controls to fuel market growth 125
TABLE 51 INDEPENDENT CONTROLS OFFERED BY KEY MARKET PLAYERS 125
TABLE 52 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
8.2.2 INSTRUMENT-SPECIFIC CONTROLS 126
8.2.2.1 Usage limitations to subdue market growth rate in favor of independent controls 126
TABLE 53 INSTRUMENT-SPECIFIC CONTROLS OFFERED BY KEY MARKET PLAYERS 127
TABLE 54 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 128
8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS 128
8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES 128
TABLE 55 OEM CONTROLS OFFERED BY KEY MARKET PLAYERS 129
TABLE 56 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
9 IVD QUALITY CONTROL MARKET, BY END USER 131
9.1 INTRODUCTION 132
TABLE 57 IVD QUALITY CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 132
9.2 HOSPITALS 132
9.2.1 HUGE VOLUME OF IVD PROCEDURES PERFORMED IN HOSPITALS TO DRIVE MARKET GROWTH 132
TABLE 58 IVD QUALITY CONTROL MARKET FOR HOSPITALS, BY COUNTRY,
2019–2026 (USD MILLION) 133
9.3 CLINICAL LABORATORIES 133
9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE THE MARKET 133
TABLE 59 IVD QUALITY CONTROL MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 135
9.4 ACADEMIC AND RESEARCH INSTITUTES 135
9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET GROWTH 135
TABLE 60 IVD QUALITY CONTROL MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 136

9.5 OTHER END USERS 137
TABLE 61 IVD QUALITY CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 137
10 IVD QUALITY CONTROL MARKET, BY REGION 138
10.1 INTRODUCTION 139
TABLE 62 IVD QUALITY CONTROL MARKET, BY REGION, 2019–2026 (USD MILLION) 139
TABLE 63 IVD QUALITY CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 140
10.2 NORTH AMERICA 140
FIGURE 37 NORTH AMERICA: IVD QUALITY CONTROL MARKET SNAPSHOT 141
TABLE 64 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 141
TABLE 65 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 142
TABLE 66 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 67 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 142
TABLE 68 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019–2026 (USD MILLION) 143
TABLE 69 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 70 NORTH AMERICA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 143
10.2.1 US 144
10.2.1.1 High healthcare expenditure in the country and the implementation of mandatory laboratory accreditation and quality assurance guidelines in laboratories to drive market growth in the US 144
TABLE 71 US: KEY MACROINDICATORS 144
TABLE 72 US: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 145
TABLE 73 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 74 US: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 145
TABLE 75 US: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 146
TABLE 76 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 77 US: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 146
10.2.2 CANADA 147
10.2.2.1 Government initiatives to promote quality controls to drive market growth in Canada 147
TABLE 78 CANADA: KEY MACROINDICATORS 147
TABLE 79 CANADA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 148
TABLE 80 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 81 CANADA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 148
TABLE 82 CANADA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 149
TABLE 83 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 84 CANADA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 149
10.3 EUROPE 150
TABLE 85 EUROPE: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 150
TABLE 86 EUROPE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 151
TABLE 87 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 88 EUROPE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 151
TABLE 89 EUROPE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 152
TABLE 90 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 91 EUROPE: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 152
10.3.1 GERMANY 153
10.3.1.1 Increasing number of certified laboratories and the rising volume of high-quality tests performed by these laboratories to support market growth in Germany 153
TABLE 92 GERMANY: KEY MACROINDICATORS 153
TABLE 93 GERMANY: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 153
TABLE 94 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 95 GERMANY: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 154
TABLE 96 GERMANY: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 154
TABLE 97 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 98 GERMANY: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 155
10.3.2 FRANCE 155
10.3.2.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market growth 155
TABLE 99 FRANCE: KEY MACROINDICATORS 156
TABLE 100 FRANCE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 156
TABLE 101 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 102 FRANCE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 157
TABLE 103 FRANCE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 157
TABLE 104 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 105 FRANCE: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 158
10.3.3 UK 158
10.3.3.1 Growth in the life science industry and increased research to drive market growth in the UK 158
TABLE 106 UK: KEY MACROINDICATORS 159
TABLE 107 UK: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 159
TABLE 108 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 109 UK: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 160
TABLE 110 UK: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 160
TABLE 111 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 112 UK: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 161
10.3.4 ITALY 161
10.3.4.1 Growing disease prevalence to drive the demand for better and more accurate disease diagnosis in Italy 161
TABLE 113 ITALY: KEY MACROINDICATORS 162
TABLE 114 ITALY: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 162
TABLE 115 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 116 ITALY: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 163
TABLE 117 ITALY: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 163
TABLE 118 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 119 ITALY: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 164
10.3.5 SPAIN 164
10.3.5.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth in Spain 164
TABLE 120 SPAIN: KEY MACROINDICATORS 164
TABLE 121 SPAIN: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 165
TABLE 122 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 123 SPAIN: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 165
TABLE 124 SPAIN: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 166
TABLE 125 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 126 SPAIN: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 166
10.3.6 RUSSIA 167
10.3.6.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market growth in Russia 167
TABLE 127 RUSSIA: KEY MACRO INDICATORS 167
TABLE 128 RUSSIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 167
TABLE 129 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 130 RUSSIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 168
TABLE 131 RUSSIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 168
TABLE 132 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 133 RUSSIA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 169
10.3.7 REST OF EUROPE 169
TABLE 134 ROE: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 170
TABLE 135 ROE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 136 ROE: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 170
TABLE 137 ROE: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 171
TABLE 138 ROE: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 139 ROE: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 171
10.4 ASIA PACIFIC 172
FIGURE 38 ASIA PACIFIC: IVD QUALITY CONTROL MARKET SNAPSHOT 173
TABLE 140 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 174
TABLE 141 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 174
TABLE 142 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 143 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 175
TABLE 144 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 175
TABLE 145 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 146 ASIA PACIFIC: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 176
10.4.1 JAPAN 176
10.4.1.1 Well-developed healthcare system and the rising demand for improvements in the quality of IVD test results to drive market growth in Japan 176
TABLE 147 JAPAN: KEY MACROINDICATORS 176
TABLE 148 JAPAN: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 177
TABLE 149 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 150 JAPAN: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 177
TABLE 151 JAPAN: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 178
TABLE 152 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 153 JAPAN: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 178
10.4.2 CHINA 179
10.4.2.1 Growing access to modern healthcare and government support to boost the market growth in China 179
TABLE 154 CHINA: KEY MACROINDICATORS 179
TABLE 155 CHINA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 180
TABLE 156 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 157 CHINA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 180
TABLE 158 CHINA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 181
TABLE 159 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 160 CHINA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 181
10.4.3 INDIA 182
10.4.3.1 Rising need to secure NABL accreditations to drive the demand for quality controls in India 182
FIGURE 39 INDIA: INCREASING NUMBER OF LABS WITH NABL ACCREDITATIONS,
2012–2020 182
TABLE 161 INDIA: KEY MACROINDICATORS 183
TABLE 162 INDIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 183
TABLE 163 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 164 INDIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 184
TABLE 165 INDIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 184
TABLE 166 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 167 INDIA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 185
10.4.4 AUSTRALIA 185
10.4.4.1 Growing geriatric population has resulted in initiatives to enhance access to healthcare and improve infrastructure 185
TABLE 168 AUSTRALIA: KEY MACROINDICATORS 186
TABLE 169 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 186
TABLE 170 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 171 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 187
TABLE 172 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 187
TABLE 173 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 174 AUSTRALIA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 188
10.4.5 SOUTH KOREA 188
10.4.5.1 Rising healthcare expenditure and the growing number of hospitals to drive the growth of the South Korean market 188
TABLE 175 SOUTH KOREA: KEY MACROINDICATORS 188
TABLE 176 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 189
TABLE 177 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 178 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 189
TABLE 179 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 190
TABLE 180 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 181 SOUTH KOREA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 190
10.4.6 REST OF ASIA PACIFIC 191
TABLE 182 ROAPAC: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 191
TABLE 183 ROAPAC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 184 ROAPAC: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 192
TABLE 185 ROAPAC: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 192
TABLE 186 ROAPAC: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 187 ROAPAC: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 193
10.5 LATIN AMERICA 193
TABLE 188 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 194
TABLE 189 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 194
TABLE 190 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 191 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 195
TABLE 192 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER, 2019–2026 (USD MILLION) 195
TABLE 193 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 194 LATIN AMERICA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 196
10.5.1 BRAZIL 196
10.5.1.1 Brazil dominates the Latin American IVD quality control market 196
TABLE 195 BRAZIL: KEY MACROINDICATORS 197
TABLE 196 BRAZIL: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 197
TABLE 197 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 198 BRAZIL: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 198
TABLE 199 BRAZIL: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 198
TABLE 200 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 201 BRAZIL: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 199
10.5.2 MEXICO 199
10.5.2.1 Mexico is emerging as a prominent medical tourism hub 199
TABLE 202 MEXICO: KEY MACROINDICATORS 200
TABLE 203 MEXICO: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 200
TABLE 204 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 200
TABLE 205 MEXICO: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 201
TABLE 206 MEXICO: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 201
TABLE 207 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 208 MEXICO: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 202

10.5.3 REST OF LATIN AMERICA 202
TABLE 209 ROLA: IVD QUALITY CONTROL MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 202
TABLE 210 ROLA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 211 ROLA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 203
TABLE 212 ROLA: IVD QUALITY CONTROL MARKET, BY MANUFACTURER,
2019–2026 (USD MILLION) 203
TABLE 213 ROLA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 214 ROLA: IVD QUALITY CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 204
10.6 MIDDLE EAST & AFRICA 204
10.6.1 RISING CANCER INCIDENCE HAS ATTRACTED STAKEHOLDER ATTENTION TO REGIONAL MARKETS IN MEA 204
TABLE 215 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 205
TABLE 216 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 217 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 206
TABLE 218 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET,
BY MANUFACTURER, 2019–2026 (USD MILLION) 206
TABLE 219 MIDDLE EAST & AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 220 MIDDLE EAST & AFRICA: IVD QUALITY CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 207
11 COMPETITIVE LANDSCAPE 208
11.1 OVERVIEW 208
11.2 KEY PLAYER STRATEGIES 209
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 210
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE IVD QUALITY CONTROL MARKET 210
11.4 MARKET SHARE ANALYSIS 210
FIGURE 41 IVD QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2020 211
11.5 COMPANY EVALUATION QUADRANT 212
11.5.1 STARS 212
11.5.2 EMERGING LEADERS 212
11.5.3 PERVASIVE PLAYERS 213
11.5.4 PARTICIPANTS 213
FIGURE 42 IVD QUALITY CONTROL MARKET: COMPANY EVALUATION QUADRANT (2020) 213
11.6 R&D EXPENDITURE 214
FIGURE 43 IVD QUALITY CONTROL MARKET: R&D EXPENDITURE (IN USD MILLION), 2020 214

11.7 COMPANY EVALUATION QUADRANT FOR START-UPS 215
11.7.1 PROGRESSIVE COMPANIES 215
11.7.2 DYNAMIC COMPANIES 215
11.7.3 STARTING BLOCKS 215
11.7.4 RESPONSIVE COMPANIES 215
FIGURE 44 IVD QUALITY CONTROL MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020) 216
11.8 COMPANY PRODUCT FOOTPRINT 217
TABLE 221 PRODUCT PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 217
FIGURE 45 TECHNOLOGY PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 218
TABLE 222 MANUFACTURER TYPE PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 219
TABLE 223 END-USER PORTFOLIO ANALYSIS: IVD QUALITY CONTROL MARKET 220
11.9 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE IVD QUALITY CONTROL MARKET 221
TABLE 224 GEOGRAPHIC REVENUE MIX: IVD QUALITY CONTROL MARKET (2020) 221
11.10 COMPETITIVE SCENARIO 222
11.10.1 PRODUCT LAUNCHES 222
TABLE 225 PRODUCT LAUNCHES 222
11.10.2 DEALS 223
TABLE 226 DEALS 223
11.10.3 OTHER DEVELOPMENTS 224
TABLE 227 OTHER DEVELOPMENTS 224